BTTX (Better Therapeutics) Total Operating Expense: $29.61 Mil (TTM As of Sep. 2023)


What is Better Therapeutics Total Operating Expense?

Better Therapeutics BTTX Total Operating Expense is $29.61 Mil as of Sep. 2023.

Better Therapeutics's Total Operating Expense for the three months ended in Sep. 2023 was $5.34 Mil. Better Therapeutics's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was $29.61 Mil.

Better Therapeutics Total Operating Expense Related Terms

Better Therapeutics Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Better Therapeutics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Better Therapeutics Total Operating Expense Chart

Better Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Total Operating Expense
4.89 5.65 30.56 38.26

Better Therapeutics Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.00 8.32 8.93 7.03 5.34

Better Therapeutics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $29.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $29.61 Mil mean?
Better Therapeutics (BTTX) has a Total Operating Expense of $29.61 Mil as of Sep. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Better Therapeutics and its competitors.
Is Better Therapeutics' Total Operating Expense too high?
Better Therapeutics' current Total Operating Expense is $29.61 Mil.
How does Better Therapeutics' Total Operating Expense compare to CYCN and CELZ?
Better Therapeutics' Total Operating Expense of $29.61 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Better Therapeutics and its competitors. Better Therapeutics's current Total Operating Expense is $29.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Better Therapeutics stock overvalued right now?
Better Therapeutics (BTTX) has a current Total Operating Expense of $29.61 Mil. The current Total Operating Expense is $29.61 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Better Therapeutics (BTTX), the current Total Operating Expense is $29.61 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Better Therapeutics Business Description

Address 548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.